Antony C. Mattessich - Net Worth and Insider Trading
Antony C. Mattessich Net Worth
The estimated net worth of Antony C. Mattessich is at least $6 Million dollars as of 2024-11-29. Antony C. Mattessich is the President and CEO of Ocular Therapeutix Inc and owns about 595,201 shares of Ocular Therapeutix Inc (OCUL) stock worth over $6 Million. Details can be seen in Antony C. Mattessich's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Antony C. Mattessich has not made any transactions after 2024-02-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Antony C. Mattessich
Antony C. Mattessich Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Antony C. Mattessich owns 2 companies in total, including Ocular Therapeutix Inc (OCUL) , and Aura Biosciences Inc (AURA) .
Click here to see the complete history of Antony C. Mattessich’s form 4 insider trades.
Insider Ownership Summary of Antony C. Mattessich
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OCUL | Ocular Therapeutix Inc | 2024-02-05 | director |
| AURA | Aura Biosciences Inc | 2021-10-28 | director |
Antony C. Mattessich Latest Holdings Summary
Antony C. Mattessich currently owns a total of 1 stock. Antony C. Mattessich owns 595,201 shares of Ocular Therapeutix Inc (OCUL) as of February 5, 2024, with a value of $6 Million.
Latest Holdings of Antony C. Mattessich
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OCUL | Ocular Therapeutix Inc | 2024-02-05 | 595,201 | 10.06 | 5,987,722 |
Holding Weightings of Antony C. Mattessich
Antony C. Mattessich Form 4 Trading Tracker
According to the SEC Form 4 filings, Antony C. Mattessich has made a total of 5 transactions in Ocular Therapeutix Inc (OCUL) over the past 5 years, including 2 buys and 3 sells. The most-recent trade in Ocular Therapeutix Inc is the sale of 19,642 shares on February 5, 2024, which brought Antony C. Mattessich around $95,460.
Insider Trading History of Antony C. Mattessich
- 1
Antony C. Mattessich Trading Performance
GuruFocus tracks the stock performance after each of Antony C. Mattessich's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Antony C. Mattessich is 1.88%. GuruFocus also compares Antony C. Mattessich's trading performance to market benchmark return within the same time period. The performance of stocks bought by Antony C. Mattessich within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Antony C. Mattessich's insider trading performs compared to the benchmark.
Performance of Antony C. Mattessich
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.94 | | | | | |
| Relative Return to S&P 500(%) | 17.78 | | | | | |
Antony C. Mattessich Ownership Network
Antony C. Mattessich Owned Company Details
What does Ocular Therapeutix Inc do?
Who are the key executives at Ocular Therapeutix Inc?
Antony C. Mattessich is the director of Ocular Therapeutix Inc. Other key executives at Ocular Therapeutix Inc include 10 percent owner Summer Road Llc , Chief Business Officer Christopher G White , and Chief Medical Officer Rabia Gurses Ozden .
Ocular Therapeutix Inc (OCUL) Insider Trades Summary
Over the past 18 months, Antony C. Mattessich made 3 insider transaction in Ocular Therapeutix Inc (OCUL) with a net sale of 31,480. Other recent insider transactions involving Ocular Therapeutix Inc (OCUL) include a net sale of 63,186 shares made by Pravin Dugel , a net sale of 14,942 shares made by Rabia Gurses Ozden , and a net sale of 2,897 shares made by .
In summary, during the past 3 months, insiders sold 28,339 shares of Ocular Therapeutix Inc (OCUL) in total and bought 0 shares, with a net sale of 28,339 shares. During the past 18 months, 164,435 shares of Ocular Therapeutix Inc (OCUL) were sold and 2,475,812 shares were bought by its insiders, resulting in a net purchase of 2,311,377 shares.
Ocular Therapeutix Inc (OCUL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocular Therapeutix Inc Insider Transactions
Antony C. Mattessich Mailing Address
Above is the net worth, insider trading, and ownership report for Antony C. Mattessich. You might contact Antony C. Mattessich via mailing address: C/o Ocular Therapeutix, Inc., 34 Crosby Dr., Suite 105, Bedford Ma 01730.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
